Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

124.81
Delayed Data
As of May 22
 -0.07 / -0.06%
Today’s Change
51.93
Today|||52-Week Range
132.99
+28.67%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 144.50, with a high estimate of 160.00 and a low estimate of 100.00. The median estimate represents a +15.78% increase from the last price of 124.81.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.74
Sales
$13.0M
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.68%
 
 
 
 
 
 
Growthannually 38.24%
 
 
 
 
 
 

Sales

Growthquarterly -29.87%
 
 
 
 
 
 
Growthannually 16.71%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account